Viewing Study NCT03872232


Ignite Creation Date: 2025-12-24 @ 9:45 PM
Ignite Modification Date: 2025-12-29 @ 2:33 PM
Study NCT ID: NCT03872232
Status: COMPLETED
Last Update Posted: 2021-01-15
First Post: 2019-03-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan
Sponsor: Addpharma Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module